An analysis by Hedge Clippers, an activist group, found 19 drugs have experienced stunning price hikes of between 300 percent and 1,200 percent over the past two years, and most of the companies responsible were backed by private capital. In related news, NBC News reports on "pay-to-delay" deals that drug makers employ to stave off generics.
No comments:
Post a Comment